What is Exer?
Exer's Clinical AI platform provides objective, real-time motion assessments without the need for wearables or sensors. By leveraging AI-powered movement data, Exer offers a clinical decision support platform, giving providers accessible, scalable, and actionable information to guide patient care.
The platform is designed to enhance clinical decision-making, personalize treatment, and enable early intervention. It is used by healthcare providers to improve patient outcomes and accessibility in various specialties, including orthopedics, neurology, pain/spine, PM&R, geriatrics, and more.
Features
- Exer Scan: Assess and monitor patients for MSK-related issues without sensors, hardware, or human error.
- Exer Health: Engage patients at-home with AI-based monitoring and real-time guidance to ensure good form and protocol adherence.
- Exer IQ: Capture outcomes, analyze population health, and predict risks with standardized or custom-built validated patient response surveys.
- Exer Hands: Support for the management of dozens of acute and chronic hand and wrist disorders like rheumatoid arthritis and carpal tunnel syndrome.
- AI-Based At-Home Patient App: Allows for remote monitoring and engagement.
- In-Clinic Scan App: Facilitates quick and objective data collection.
- Real-Time Data Portal Backend: Provides instant analysis and reporting.
- Automated Billing Reports: Streamlines billing processes.
- Standardized Outcome Measures: Ensures consistent evaluation.
- Customizable Templates: Adapts to specific clinical needs.
- Daily Engagement Tools: Enhances patient adherence
Use Cases
- Orthopedic operative and conservative care
- Senior care fall prevention
- Neurological disorder evaluation and monitoring
- Primary care MSK issue identification
- Rehabilitation treatment planning and monitoring
- Health plan support for value-based care
Helpful for people in the following professions
Featured Tools
Join Our Newsletter
Stay updated with the latest AI tools, news, and offers by subscribing to our weekly newsletter.